High level of CA 125 due to large endometrioma

Journal of the Medical Association of Thailand

Volumn 87, Issue 9, 2004, Pages 1108-1111

  Phupong, Vorapong ^a   Chen, Orawan ^a   Ultchaswadi, Pornthip ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Benign; CA 125; Endometrioma; Ovary

Indexed keywords

CA 125 ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; ECHOGRAPHY; ENDOMETRIUM TUMOR; FEMALE; FOLLOW UP; GYNECOLOGIC DISEASE; HOSPITAL DISCHARGE; HUMAN; HYSTERECTOMY; LEIOMYOMA; OVARY CANCER; OVARY TUMOR; PREOPERATIVE PERIOD;

CA-125 ANTIGEN; ENDOMETRIOSIS; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; OVARIAN DISEASES;

EID: 5444238655     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Colacurci N, Fortunato N, De Francisas P, Fratta M, Cioffi M, Zarcone R, et al. Serum and peritoneal CA-125 levels as diagnostic test for endometriosis. Eur J Obstet Gynecol Reprod Biol 1996; 66: 41-3.
2. Niloff JM, Knapp RC, Schaetzl E, Reynolds C, Bast RC, Jr. CA125 antigen levels in obstetric and gynecologic patients. Obstet Gynecol 1984; 64: 703-7.
3. Malkasian GD, Jr., Knapp RC, Lavin PT, Zurawski VR, Jr., Podratz KC, Stanhope CR, et al. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease. Am J Obstet Gynecol 1988; 159: 341-6.
4. Einhorn N, Bast RC, Jr., Knapp RC, Tjernberg B, Zurawski VR, Jr. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer. Obstet Gynecol 1986; 67: 414-6.
5. Giudice LC, Jacobs AJ, Bell CE, Lippmann L. Serum levels of CA-125 in patients with endometriosis. Gynecol Oncol 1986; 25: 256-8.
6. Nagata H, Takahashi K, Yamane Y, Yoshino K, Shibukawa T, Kitao M. Abnormally high values of CA 125 and CA 19-9 in women with benign tumors. Gynecol Obstet Invest 1989; 28: 165-8.
7. Kammerer-Doak DN, Magrina JF, Nemiro JS, Lidner TK. Benign gynecologic conditions associated with a CA-125 level > 1,000 U/mL. A case report. J Reprod Med 1996; 41: 179-82.
8. Kashyap RJ. Extremely elevated serum CA125 due to endometriosis. Aust N Z J Obstet Gynaecol 1999; 39: 269-70.
9. Check JH, Hornstein MD. Endometriosis causing very high early first trimester serum CA 125 levels. Int J Gynaecol Obstet 1995; 48: 217-8.
10. Atabekoglu CS, Sonmezer M, Aydinuraz B, Dunder I. Extremely elevated CA 125 level due to an unruptured large endometrioma. Eur J Obstet Gynecol Reprod Biol 2003; 110: 105-6.
11. Johansson J, Santala M, Kauppila A. Explosive rise of serum CA 125 following the rupture of ovarian endometrioma. Hum Reprod 1998; 13: 3503-4.
12. Bast RC, Jr., Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981; 68: 1331-7.
13. Daoud F, Boder G. CA-125 concentrations in malignant and nonmalignant disease. Clin Chem 1991; 37: 1968-74.
14. Bast RC, Jr., Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983; 309: 883-7.
15. Soper JT, Hunter VJ, Daly L, Tanner M, Creasman WT, Bast RC, Jr. Preoperative serum tumor-associated antigen levels in women with pelvic masses. Obstet Gynecol 1990; 75: 249-54.
16. Pittaway DE. CA-125 in women with endometriosis. Obstet Gynecol Clin North Am 1989; 16: 237-52.
17. Check JH, Coates TE, Nowroozi K. Extreme elevation of serum CA-125 in two women with severe endometriosis: case report. Gynecol Endocrinol 1991; 5: 217-20.
18. Cheng YM, Wang ST, Chou CY. Serum CA-125 in preoperative patients at high risk for endometriosis. Obstet Gynecol 2002; 99: 375-80.
19. Barbieri RL, Niloff JM, Bast RC, Jr., Scaetzl E, Kistner RW, Knapp RC. Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril 1986; 45: 630-4.
20. Phupong V, Sueblinvong T, Triratanachat S. Ovarian teratoma with diffused peritoneal reactions mimicking advanced ovarian malignancy. Arch Gynecol Obstet (Inpress) DOI 10.1007/s00404-003-0479-8.